Research has found that FOXP3, although as a marker for T cells, is rarely expressed in healthy cell tissues but is aberrantly upregulated in various malignant tumors, such as lung cancer [53], pancreatic cancer [54], thyroid cancer [55], and T-cell lymphoma [56]. Here, FOXP3 is linked to cancer.